Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


Industry content

Industry content

Welcome to the Industry Content Hub!

This is where you'll find all there is to know about our industry in Europe.





phacilitate leaders europe reports and articles

Investment Report

The advanced therapy sector is a rapidly growing industry which offers substantial investment opportunities for those able to understand and overcome the significant challenges to successful commercialisation.

phacilitate leaders europe reports and articles

How to find the perfect CRO?

Successful development of advanced therapies relies on robust CRO partnerships but the industry is facing huge challenges with identifying and selecting the right partner with the right expertise.

Phacilitate Leaders Europe videos

Are we ready for a $5m gene therapy?

Episode two of the Phacilitate Leaders World super plenary discussions sees Anthony Davies quizzing Dave Lennon about the projected cost of Zolgensma, which, at the time of filming was in the $4-5m range.

Phacilitate Leaders Europe videos

HTA and Industry Perspectives

Watch the whole presentation on 'Profiling the current environment and predicting the future for ATMP evaluation, pricing and reimbursement in Europe

phacilitate leaders europe gene editing technology review advanced therapies

Technology Review: Gene Editing

Edition one of Phacilitate's technology review series examines gene editing approaches by viral and non-viral methods and where to access these services

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd